Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 6/20 | 0.38 |
| ▸ | PKM | P14618 | 2/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.36 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.36 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.35 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15465905 | 0.90 | EPHX2 (0.42) | EPHX2P2RX7AR | |
| SCHEMBL794705 | 0.89 | EPHX2 (0.35) | EPHX2P2RX7 | |
| SCHEMBL794733 | 0.89 | EPHX2 (0.36) | EPHX2P2RX7 | |
| SCHEMBL794609 | 0.87 | EPHX2 (0.40) | EPHX2PKMCYP2D6CYP2C19ALDH1A1 | |
| SCHEMBL17857813 | 0.84 | EPHX2 (0.41) | EPHX2PKMCYP2D6CYP2C19ALDH1A1 | |
| SCHEMBL794660 | 0.83 | EPHX2 (0.37) | EPHX2PKMCYP2D6CYP2C19ALDH1A1 | |
| SCHEMBL794431 | 0.82 | EPHX2 (0.42) | EPHX2KCNH2MCHR1P2RX7AR | |
| SCHEMBL793993 | 0.82 | EPHX2 (0.40) | EPHX2PKMCYP2D6CYP2C19P2RX7 | |
| SCHEMBL15466565 | 0.81 | EPHX2 (0.41) | EPHX2P2RX7 | |
| SCHEMBL15466459 | 0.81 | KCNH2 (0.39) | EPHX2KMT2AKCNH2MCHR1AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9375000-B2 | Pesticidal arylpyrrolidines | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2016-06-28 | — | — | US | disclosed |
| CN-103282347-B | Pesticidal arylpyrrolidines | BAYER IP GMBH | 2015-04-01 | — | — | CN | disclosed |
| US-20140046069-A1 | PESTICIDAL ARYLPYRROLIDINES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140046069-A1 | PESTICIDAL ARYLPYRROLIDINES | DDT, ACHE, CAT | EPHX2 1332/4885PKM 721/4885CYP2D6 199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.